Prevention Is Indisputably Cost Effective
Lantis Laser – StockGuru Profile Lantis – OTC: LSSR.PK
Aggressive Treatment of Gingivitis Shows Significant Improvement in Arterial Elasticity
A recent study indicates patients given a deep-cleaning gum treatment, along with antibiotics, and the removal of, on average, two teeth which could no longer be treated successfully, experienced an important and statistically significant improvement in arterial elasticity at two months after treatment, with the effect being greater at six months.
The study enrolled 120 otherwise healthy patients with a severe form of periodontitis in a six-month trial and compared the effects of regular tooth cleaning with those of intensive periodontal treatment (scaling and root planing, locally administered antibiotics and tooth extraction, when necessary). The intensive treatment group showed important and statistically significant improvements in blood flow (as measured by brachial arterial dilation) within two months of treatment. The improvement was greater six months after treatment.
“In recent years, there have been numerous hypotheses linking periodontal infections to atherosclerosis – the process that leads to blockage of blood vessels,” notes Dr. Tonetti. “This study validates the effectiveness of intensive periodontal treatment in affecting vascular health.”
Currently, more than one in three Americans over age 30 have some form of periodontitis, according to the American Academy of Periodontology. Cardio Vascular Disease is the single largest killer of American adults; in 2003, it caused one of every five deaths in the United States. Unfortunately, periodontal infections often go untreated, creating a chronic inflammatory burden that may result in systemic inflammation, possibly contributing to broader health problems.
Lantis Laser with Optical Coherence Tomography (OCT) has exclusive rights to the application of OCT technology in the field of dentistry under its license Agreements with Lawrence Livermore National Laboratory and LightLab Imaging. OCT creates a noninvasive technique for imaging subsurface tissue structure with micrometer-scale resolution. Lantis Laser’s imaging system provides the dentist with the ability to image both the teeth and the gums. This technology is able to detect early stage disease in oral tissue AND capture it sooner than has historically been possible with a minimally invasive procedure.
Gum Disease Related to Cardiovascular Health
About 30 per cent of people worldwide are susceptible genetically to gum disease, according to the American Academy of Periodontology, based in Chicago. Gum disease has been linked to inflammation, a risk factor in heart disease, said Maurizio Tonetti, the lead author of the new study. Hardened blood vessels are associated with heart attacks and strokes.
Dr. Tonetti is a former professor of periodontology at the University of Connecticut, Farmington. “This is the first study that unequivocally establishes a link between gum infections and general health and well-being. ”
Tonetti and his team set out to find whether gum disease caused blood vessel dysfunction, and if an intensive treatment could change the early signs of hardened arteries.
A control group in the study received regular tooth cleaning and instructions in brushing and flossing. The researchers said they found no changes in the elasticity of these patients’ blood vessels.
Other patients were given a deep-cleaning treatment, along with antibiotics, and underwent removal of, on average, two teeth which could no longer be treated successfully, Tonetti said.
“In this group, we saw an important and statistically significant improvement in arterial elasticity already at two months after treatment, with the effect being greater at six months,” Tonetti said.
He suggested that people prevent gum disease by brushing and flossing, and by talking to their dentists about prevention and early treatment.
About three million people in the U.S. may have gum disease as severe as the cases in the study, according to the researchers.
Patients in the study experienced short-term inflammation immediately after initial treatment, according to the report.
The study published in the New England Journal of Medicine is promising for patients, the medical and dental communities and for health insurance carriers. Prevention is less expensive than treatment. This study adds to the growing body of evidence and underscores the potential impact of infection and subsequent inflammation on systemic diseases.
This is a perfect example of the studies that are mounting weekly which tie oral health to overall health. This body of evidence is the factor which has motivated health insurance carriers to begin to reimburse patients for issues related to oral health.
Never before in the history of dentistry has early detection of gum disease and decay been more relevant to patient care and overall health care cost efficiencies.
Lantis Laser has the exclusive license with the Lawrence Livermore National Laboratory and Light Lab Imaging. They will be the only company selling this device. It is their intention to make this device affordable for the average dentist and they expect demand to be high.
Lantis Laser provides a crucial tool for prevention!
Source: Lantis Laser Inc., Business Week, Prescription RX, New England Journal of Medicine, American Academy of Periodontology
Contact: Lantis Laser Inc.
Stan Baron,President and CEO
11 Stonebridge Court
Denville, NJ 07834
Tel: (203) 300-7622
Forward-Looking Statements: Certain statements in this press release, including statements regarding the anticipated development and expansion of Lantis’ business, and the intent, belief or current expectations of Lantis, its directors or its officers, are forward-looking statements. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statement.
Disclosure: Pentony Enterprises LLC was compensated $27,000 and 70,000 restricted shares directly from the company and 55,000 free trading shares from a non controlling third party for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. It is the policy of Pentony Enterprises LLC to sell all shares of this and any company featured. Anyone considering any company we feature in consideration for free trading shares should consider this. Pentony Enterprises no longer holds shares.
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (214) 458-4258. Web: StockGuru.com. Email: Publisher@stockguru.com.
